Neuspera Medical Announces First Successful Implant of the Nuvella™ System in the Second Phase of Its Sans-Uui Ide Clinical Trial
On October 10, 2022, Neuspera Medical, a medical device company involved in the development of implantable devices for patients suffering from chronic illnesses, announced that the first patient had been successfully implanted with the Nuvella™ system in its pivotal clinical trial (SANS-UUI).
The study aims to evaluate the safety and efficacy of the Nuvella system, that is designed for the treatment of overactive bladder (OAB) with sacral neuromodulation (SNM) in patients showing symptoms of urinary urgency inconti...
